GILD catalysts
Catalysts and events linked to GILD, newest first.
DateCardAvg 5d
- 2026-09-16CAR-T oncology market expands as ALL and lymphoma therapies target long-term growthAUTL GILD NVS
- 2026-09-16CAR-T oncology market expands as ALL and lymphoma therapies target long-term growthAUTL GILD NVS
- 2026-09-11GSK Specialty Medicines Grow 14% as Company Prepares 20 Phase III Starts Ahead of Patent CliffGILD GSK
- 2026-09-11GSK Specialty Medicines Grow 14% in H1 2026 Ahead of 2028 HIV Patent CliffGILD GSK
- 2026-09-02Gilead secures FDA approval for Bixlenvo, raises 2026 HIV sales outlook to 9-10%GILD GSK
- 2026-09-02Gilead secures FDA approval for Bixlenvo, raises 2026 HIV sales outlook to 9-10%GILD GSK
- 2026-09-02FDA approves Gilead's Bixlenvo as HIV franchise sales outlook raised to 9-10%GILD
- 2026-09-02Gilead secures FDA approval for Bixlenvo and lifts 2026 HIV sales outlookGILD
- 2026-09-02Gilead secures FDA approval for Bixlenvo, raises 2026 HIV sales outlook to 9-10%GILD GSK
- 2026-09-02FDA approves Gilead's Bixlenvo as HIV franchise sales outlook raised to 9-10%GILD GSK
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.